Wishart, G;
Gupta, P;
Nisbet, A;
Velliou, E;
Schettino, G;
(2021)
Novel anticancer and treatment sensitizing compounds against pancreatic cancer.
Cancers
, 13
(12)
, Article 2940. 10.3390/cancers13122940.
Preview |
Text
Nisbet_Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer_VoR.pdf - Published Version Download (1MB) | Preview |
Abstract
The isolation of chemical compounds from natural origins for medical application has played an important role in modern medicine with a range of novel treatments having emerged from various natural forms over the past decades. Natural compounds have been exploited for their antioxidant, antimicrobial and antitumor capabilities. Specifically, 60% of today’s anticancer drugs originate from natural sources. Moreover, the combination of synthetic and natural treatments has shown applications for (i) reduced side effects, (ii) treatment sensitization and (iii) reduction in treatment resistance. This review aims to collate novel and natural compounds that are being explored for their preclinical anticancer, chemosensitizing and radiosensitizing effects on Pancreatic Ductal Adenocarcinoma (PDAC), which is a lethal disease with current treatments being inefficient and causing serve side effects. Two key points are highlighted by this work: (i) the availability of a range of natural compounds for potentially new therapeutic approaches for PDAC, (ii) potential synergetic impact of natural compounds with advanced chemo-and radio-therapeutic modalities for PDAC.
Archive Staff Only
 |
View Item |
